Programme 2023
Day 1 - Programme
08:30
REGISTRATION, COFFEE, NETWORKING
09:15
WELCOME
Cécile Oury
STATE OF THE ART I – NEW APPLICATIONS FOR OLD TESTS
Chairs: Katrien Devreese & Jan Emmerechts
09:30
Update on viscoelastic testing
Pieter De Kesel (Gent, Belgium)
10:00
Update on platelet aggregation testing
François Mullier (Namur, Belgium)
SPONSORED SATELLITE SYMPOSIUM I - PFIZER
10:30
Unmet need and therapeutic developments in Haemophilia
Cedric Hermans ((Université Catholique de Louvain Saint-Luc, Belgium)
Cedric Hermans, MD, PhD, FRCP (Lon, Edin)
Division of Haematology
Cliniques universitaires Saint-Luc
Catholic University of Louvain, Brussels, Belgium
Cedric Hermans currently heads the Division of Haematology, the Hemostasis and Thrombosis Unit as well as the Hemophilia Center of the Saint-Luc University Hospital in Brussels, Belgium. He was appointed Associate Professor at the Medical School of the Catholic University of Louvain in 2003, Full Professor in 2012 and ViceDean in 2015.
Professor Hermans has (co)-authored more than 330 original articles in international journals and is a member of several scientific societies and international advisory boards and collaborative research projects.
He was president of EAHAD and is currently member of the Board of Directors of the World Federation of Haemophilia, associate member of the Belgian Royal Academy of Medicine and the Editor-in-Chief of the Haemophilia Journal.
His main research interests lie in the area of haemostasis and thrombosis, especially clinical studies on the treatment modalities and the wide spectrum of complications of haemophilia in both developed and developing countries, as well as new anticoagulants and the management of thrombosis.
11:30
COFFEE BREAK
SELECTED ORAL PRESENTATIONS – BASIC RESEARCH
Chairs: Cécile Oury & Simon Demeyer
12:00
O1 Analysis of the ultrastructural architecture of ischemic stroke thrombi using scanning electron microscopy: an observational study
Sarah Vandelanotte (KU Leuven - KULAK)
12:15
O2 Septic shock is associated with a substantial change in the platelet lipidome
Melanie Dechamps (UCL)
12:30
O3 Absence of mitochondrial deacetylase SIRT3 results in enhanced platelet apoptosis
Jens Van Bael (KU Leuven - KULAK)
12:45
O4 Ticagrelor targets multiple lipids in the bacterial cytoplasmic membrane of multidrug resistant staphylococci
Kirsten Leeten (ULiège)
13:00
LUNCH AND POSTER WALK
14:00
BSTH GENERAL ASSEMBLY
Only accessible for members of the BSTH
EDUCATIONAL I
Chair: Christelle Orlando
14:30
Congenital disorders of glycosylation
M-E De La Morena-Barrio (Murcia, Spain)
EDUCATIONAL II
Chair: Sandrine Horman
15:15
Managing antithrombotic therapy in patients on mechanical circulatory support anno 2023: are we there yet?
Christophe Vandenbriele (London, UK)
16:00
COFFEE BREAK
PROFESSOR GASTON BAELE MEMORIAL LECTURE
Chair: Cécile Oury
16:30
Serendipity in the scientific career of an academic scientist
Paul Declerck (Leuven, Belgium)
17:15
PAUL CAPEL PRIZE - BASIC RESEARCH
Chair: Cécile Oury
17:30
CLOSURE OF DAY PROGRAMME
19:00
Dinner
Day 2 - Programme
08:30
REGISTRATION, COFFEE, NETWORKING
STATE OF THE ART II: – UPDATE ON ANTICOAGULANT TREATMENT
Chairs: Thomas Vanassche & Philip Maes
09:00
Thrombophilia and anticoagulant treatment in pregnancy: what's new?
Saskia Middeldorp (Nijmegen, The Netherlands)
09:30
FXI inhibitors: where do we stand?
Antonio Greco (Catania, Italy)
SPONSORED SATELLITE SYMPOSIUM II - VIATRIS
Chair: Harlinde Peperstraete
10:00
VTE prophylaxis in medically ill patients
Thomas Vanassche
10:20
Arixtra in medically ill patients
Alexander Cohen
10:50
Q&A
Harlinde Peperstraete
11:00
COFFEE BREAK
SELECTED ORAL PRESENTATIONS – CLINICAL AND LABORATORY
Chairs: Phu Quoc Le & Kristel Vandenbosch
11:30
O5 European practices on antithrombotic management during percutaneous mechanical circulatory support in adults: An international survey of the ACVC of the ESC joint with the EuroELSO
Charlotte Van Edom (KU Leuven)
11:45
O6 Correlation between ETP-based APC Resistance and the Relative Risk of Venous Thromboembolism in Women Using Combined Oral Contraceptives
Laure Morimont (Qualiblood / Université Namur)
12:00
07 Investigating phenotype – genotype relationships in patients with PROC or PROS1 variants
Marthe Vanrentergem (UZ Leuven)
12:15
O8 The novel p.C1130S mutation is responsible for the complex phenotype in a Finnish family with VWD
Bas Calcoen (KU Leuven / KULAK)
12:30
CSL BEHRING ENCOURAGEMENT AWARD
12:45
LUNCH AND POSTER WALK
EDUCATIONAL III
Chair: Jan Emmerechts
13:45
Bleeding and thrombosis in myeloproliferative disorders
Steffen Koschmieder (Aachen, Germany)
STATE OF THE ART III: UPDATE ON DOAC
Chairs: Christelle Orlando & Laure Gilis
14:30
Treatment of thrombotic antiphospholipid syndrome: beyond vitamin-K antagonists
Hannah Cohen (London, UK)
15:00
When not to use DOACs
Peter Verhamme (Leuven, Belgium)
15:30
PAUL CAPEL PRIZE – CLINICAL AND LABORATORY
Chair: Cécile Oury
15:45
CLOSING REMARKS